Reviewing and identifying amino acids of human, murine, canine and equine TLR4 / MD-2 receptor complexes conferring endotoxic innate immunity activation by LPS/lipid A, or antagonistic effects by Eritoran, in contrast to species-dependent modulation by lipid IVa

Computational and Structural Biotechnology Journal

Volumn 5, Issue 6, 2013, Pages e201302012-

  Scior, Thomas ^a   Alexander, Christian ^b   Zaehringer, Ulrich ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Lipopolysaccharide; MD 2; Toll like receptors

Indexed keywords

EID: 84902198504     PISSN: None     EISSN: 20010370     Source Type: Journal    
DOI: 10.5936/csbj.201302012     Document Type: Short Survey

References (57)

1. Gioannini TL, Teghanemt A, Zhang D, Coussens NP, Dockstader W, et al. (2004) Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Nad Acad Sci USA 101 4186-4191. (Pubitemid 38405904)
2. Bryant CE, Spring DR, Gangloff M, Gay NJ (2010) The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol
3. King JD, Kocincova D, Westman EL, Lam JS (2009) Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun 15(5):261-312.
4. Ittig S, Lindner B, Stenta M, Manfredi P, Zdorovenko E, et al. (2012) The lipopolysaccharide from Capnocytophaga canimorsus reveals an unexpected role of the core-oligosaccharide in MD-2 binding. PLoS Pathog 8(5):el002667.
5. Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjostedt A, et al. (2006) Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun 74:6730-6738. (Pubitemid 44913147)
6. Piazza M, Yu L, Teghanemt A, Gioannini T, Weiss J, Peri F (2009) Evidence of a specific interaction between new synthetic antisepsis agents and CD14. Biochemistry 48 (51):12337-12344.
7. Resman N, Vasl J, Oblak A, Pristovsek P, Gioannini TL, et al. (2009) Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J Biol Chem 284(22):15052-15060.
8. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458(7242):1191-1195.
9. Alexander C, Rietschel ET (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7(3):167-202. (Pubitemid 32894573)
10. Visintin A, Iliev DB, Monks BG, Halmen KA, Golenbock DT (2006) MD-2. Immunobiology211(6-8):437-447.
11. Ohto, U, Fukase K, Miyake K, Satow Y (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVA. Science 316:1632-1634. (Pubitemid 46982039)
12. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal Structure of the MD-2 /TLR4 Complex with Bound Endotoxin Antagonist Eritoran. Cell 130:906-917. (Pubitemid 47332573)
13. Yoon SI, Hong M, Wilson IA (2011) An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1. Nat. Struct. Mol. Biol 18(9):1028-1035.
14. Ohto U, Miyake K, Shimizu TJ (2011) Crystal Structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the Toll-like receptor family. J Mol Biol 413(4):815-825.
15. Ohto U, Fukase K, Miyake K, Shimizu T (2012) Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Nad Acad Sci USA 109(19):7421-7426.
16. Raetz CR, Reynolds CM, Trent MS, Bishop RE (2007) Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76:295-329.
17. Berezow AB, Ernst RK, Coats SR, Braham PH, Karimi-Naser LM, Darveau RP (2009) The structurally similar, penta-acylated lipopolysaccharides of Porphyromonasgingivalis and Bacteroides elicit strikingly different innate immune responses. MicrobPathog 47:68-77.
18. Zahringer U, Salvetzki R, Wagner F, Lindner B, Ulmer AJ (2001) Structural and biological characterisation of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes. J Endotoxin Res 7(3); 133-146. (Pubitemid 32677611)
19. Kawasaki K, Ernst RK, Miller SI (2004) 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem 279(19):20044-20048. (Pubitemid 38623448)
20. Saitoh S, Akashi S, Yamada T, Tanimura N, Kobayashi M., et al. (2004) Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int Immunol 16:961-969. (Pubitemid 38960874)
21. Somerville JE Jr., Cassiano L, Bainbridge B, Cunningham MD, Darveau RP (1996) A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest 97:359-365. (Pubitemid 26039398)
22. Teghanemt A, Zhang D, Levis EN, Weiss JP, Gioannini TL (2005) Molecular basis of reduced potency of underacylated endotoxins. J Immunol 175:4669-4676. (Pubitemid 41362008)
23. Bainbridge BW, Coats SR, Pham TT, Reife RA, Darveau RP (2006) Expression of a Porphyromonasgingivalis lipid Apalmitylacyltransferase in Escherichia coli yields a chimeric lipid A with altered ability to stimulate interleukin-8 secretion. Cell Microbiol 8:120-129. (Pubitemid 43355526)
24. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, et al. (2009) Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell Microbiol 11:1587-1599.
25. Curtis MA, Percival RS, Devine D, Darveau RP, Coats SR, et al. (2011) Temperature-dependent modulation of Porphyromonasgingivalis lipid A structure and interaction with the innate host defenses. Infect Immun 79:1187-1193.
26. Herrera CM, Hankins JV, Trent MS (2010) Activation of PmrA inhibits LpxT-dependent phosphorylation of lipid A promoting resistance to antimicrobial peptides. Mol Microbiol 76:1444-1460.
27. Ingram BO, Sohlenkamp C, Geiger O, Raetz CRH (2010) Altered lipid A structures and polymyxin hypersensitivity of Rhizobium etli mutants lacking the LpxE and LpxF phosphatases. Biochim Biophys Acta 1801:593-604.
28. Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC (2007) The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316:1628-1632. (Pubitemid 46982038)
29. Wang X, McGrath SC, Cotter RJ, Raetz CRH (2006) Expression cloning and periplasmic orientation of the Francisella novicida lipid A 4'- phosphatase LpxF. J Biol Chem 281:9321-9330. (Pubitemid 43864648)
30. Zahringer U, Lindner B, Inamura S, Heine H, Alexander C (2008) TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213(3-4):205-224.
31. Rietschel ET, Kirikae T, Schade UF, Mamat U, Schmidt G (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217-225. (Pubitemid 24067145)
32. Kusumoto S, Fukase K, Fukase Y, Kataoka M, Yoshizaki H, Sato K, Oikawa M, Suda Y. (2003) Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs. J Endotoxin Res. 9(6):361-366. (Pubitemid 38035599)
33. Schletter J, Heine H, Ulmer AJ, Rietschel ET (1995) Molecular mechanisms of endotoxin activity. Arch Microbiol 164:383-389. (Pubitemid 26018509)
34. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700. (Pubitemid 34800232)
35. Kumar H, Kawai T, Akira S (2009) Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388(4):621-625.
36. Muroi M, Tanamoto K (2006) Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa. J BiolChem 281(9):5484-5491. (Pubitemid 43847643)
37. Meng J, Lien E, Golenbock DT (2010) MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J BiolChem 285(12):8695-8702.
38. Yoon SI, Hong M, Han GW, Wilson IA (2010) Crystal structure of soluble MD-1 and its interaction with lipid IVa. Proc Natl Acad Sci USA 107(24): 10990-10995.
39. Bates JM, Akerlund J, Mittge E, Guillemin K (2007) Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2(6):371-382. (Pubitemid 350215326)
40. Qureshi N, Takayama K, Kurtz R (1991) Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonassphaeroides is an endotoxin antagonist in mice. Infect Immun 59(l):44l-444.
41. Homma JY, Matsuura M, Kumazawa Y (1990) Structure-activity relationship of chemically synthesized nonreducing parts of lipid A analogs. Adv Exp Med Biol 256:101-119. (Pubitemid 20244400)
42. Takada H, Kotani S (1989) Structural requirements of lipid A for endotoxicity and other biological activities. Crit Rev Microbiol 16:477-523.
43. Fujimoto Y, Adachi Y, Akamatsu M, Fukase Y, Kataoka M, et al. (2005) Synthesis of lipid A and its analogues for investigation of the structural basis for their bioactivity. J Endotoxin Res 11 (6):34l-347.
44. Rietschel ET, Kirikae T, Schade FU, Ulmer AJ, Hoist O, et al. (1993) The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187(3-5): 169-190. (Pubitemid 23150766)
45. Lohmann KL, Vandenplas M, Barton MH, Moore JN (2003) Lipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells. J Endotoxin Res 9(l):33-37. (Pubitemid 36322482)
46. Stewart I, Schluter PJ, Shaw GR (2006) Cyanobacterial lipopolysaccharides and human health - a review. Environ Health 24(5):7-35.
47. Ernst RK, Hajjar AM, Tsai JH, Moskowitz SM, Wilson CB, Miller SI (2003) Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor. J Endotoxin Res 9(6):395-400. (Pubitemid 38035605)
48. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. (Review) Nat Immunol 5(10):987-995. (Pubitemid 41057715)
49. Raetz CR (1990). Biochemistry of endotoxins .Annu Rev Biochem 59:129-170.
50. Kumada H, Haishima Y, Watanabe K, Hasegawa C, Tsuchiya T, et al. (2008) Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide. Oral Microbiol Immunol 23:60-69. (Pubitemid 350308569)
51. Meng J, Drolet JR, Monks BG, Golenbock DT (2010) MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid FVA. J Biol Chem 285(36):27935-27943.
52. Walsh C, Gangloff M, Monie T, Smyth T, Wei B, et al. (2008) Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J Immunol 181(2):1245-1254.
53. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, et al. (2000) Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105(4):497-504. (Pubitemid 30127250)
54. Beutler B, Poltorak A (2000) The search for Lps: 1993-1998. J Endotoxin Res 6(4):269-293. (Pubitemid 32140708)
55. Prohinar P, Re F, Widstrom R, Zhang D, Teghanemt A, et al. (2007) Specific high affinity interactions of monomeric endotoxin protein complexes with Toll-like receptor 4 ectodomain. J Biol Chem282(2):1010-1017. (Pubitemid 47076551)
56. Nyman T, Stenmark P, Flodin S, Johansson I, Hammarstrom M, Nordlund P (2008) The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem283(18):l 1861-11865.
57. Panter G, Jerala R (2011) Theectodomain of the Toll-like receptor 4 prevents constitutive receptor activation. J Biol Chem 286(26):23334-2344.